Field news
Proposed visa caps could shrink the pipeline of foreign-trained researchers
A Trump administration proposal would limit visas for international Ph.D. students and postdocs to four years, and experts warn it could push scientific talent out of U.S. labs and clinical research programs. For HealthTech and academic medicine, this raises real questions about who trains the next generation of investigators and how research pipelines stay competitive. Read more via STAT News.
Read the source →Field news
FDA staff push back on Replimune's skin cancer data package
Regulators at the FDA reiterated that Replimune's investigational skin cancer treatment lacks adequate data to support approval, a signal worth watching for oncologists and clinical trial designers weighing how regulatory scrutiny is evolving. It's a reminder that internal FDA review notes often diverge from sponsor narratives well before a final decision. Details via STAT News.
Read the source →Field news
FDA disputes Capricor's Duchenne trial success claims
The FDA said Capricor's stem cell treatment for Duchenne muscular dystrophy did not meet its Phase 3 trial objectives, contradicting the company's public claims — a gap that matters for physicians counseling families on emerging therapies for rare pediatric disease. This kind of company-vs-regulator discrepancy underscores why independent, physician-vetted review of trial data remains essential. Full rundown via STAT News.
Read the source →Help & guides
How you can take part today
If you're a licensed physician, you can join our credential verification queue to help build a validator panel the field can actually trust. Verified clinicians are also invited into Consensus Cases, where collective review generates a defensible dataset for labs and HealthTech teams building on real clinical judgment — not synthetic guesses. Prefer live discussion? Sala Clínica hosts moderated professional conversation on the news of the week, and Real Training offers four clinical tasks per session, each scored against a transparent rubric.